Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
about
How to manage aspergillosis in non-neutropenic intensive care unit patientsTherapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectivePopulation pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies.Voriconazole pharmacokinetics and pharmacodynamics in children.Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products.Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapyClinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.Human pharmacogenomic variations and their implications for antifungal efficacy.Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adultsComparative pharmacokinetics of voriconazole administered orally as either crushed or whole tabletsPharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature.Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states.Single-dose phase I study to evaluate the pharmacokinetics of posaconazole in new tablet and capsule formulations relative to oral suspension.Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.Effect of varying amounts of a liquid nutritional supplement on the pharmacokinetics of posaconazole in healthy volunteers.Pharmacology and clinical use of voriconazole.Voriconazole therapeutic drug monitoring: focus on safety.Opportunistic invasive fungal infections: diagnosis & clinical management.Therapeutic drug monitoring of voriconazole and posaconazole.Pharmacogenomics of the triazole antifungal agent voriconazole.Update on the optimal use of voriconazole for invasive fungal infections.Triazole antifungal agents in invasive fungal infections: a comparative review.Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.Pharmacokinetic considerations in treating invasive pediatric fungal infections.Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.Role of therapeutic drug monitoring of voriconazole in the treatment of invasive fungal infections.Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre.Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children.Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.Enteral voriconazole induced hypoglycemia: A potentially life threatening complication.Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient VariabilityA Case of Localized Cutaneous Infection Caused by Scedosporium apiospermum Presenting as CellulitisVoriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.A Review of Food-Drug Interactions on Oral Drug Absorption.Voriconazole: Poor Oral Bioavailability and Possible Renal Toxicity in an Infant With Invasive Aspergillosis.Pharmacology of Systemic Antifungal Agents
P2860
Q26999448-27688C97-A8D7-45EA-9F69-74E904828AF6Q27009221-742A6FB4-889B-4F62-B3E7-41DE419888B6Q33392206-D9613401-329D-4FB0-9BD2-8FD0F243A476Q33577291-DC62D08B-B8AF-462D-BE27-3A8B0F2231C9Q34101250-A02DCB5E-D751-49DB-8548-B5D8A2EFD56CQ34413393-30A336C6-F196-4647-AD1A-E949DF80C629Q34505582-442AC051-C12D-4B54-B7FB-BA5476DAA97BQ34596313-8CC6721A-CDC9-419C-9418-32E5C7216EF3Q35070838-8E7BB6C8-9898-435E-BAB5-3F7512982217Q35635928-800432B1-CEEA-49ED-9B83-FC7C119EF6B7Q35647746-A9FD7B7D-C222-4CD4-BDF8-E880F7B7113BQ35959476-6A35CFDA-52B2-4EF5-A751-4B276E099920Q35960882-31769662-E3B6-4D24-A082-F63177730B3CQ36171677-9B3BCC49-3432-48C0-A9E1-E8B5BC776F5FQ36927577-1AA8831B-E598-43F7-88EA-862833FBEEBAQ37115829-D59E8F73-FC09-4271-AF82-51CBFAB8AD38Q37409875-1A6704B5-5737-4E46-8D53-C5C88ABCF201Q37641375-B5889FFB-A9C4-4985-9733-98512361A3F9Q37658869-E794683F-601A-4545-B393-AADAFC323166Q37726198-0FF7B0BA-81DF-45C1-B51B-B26B97BAF637Q37833074-8B769E34-DE03-4030-ABDA-00DF9B4B0063Q37892536-75DCEA59-DE2A-420C-B3AE-3E6EB82772C4Q37892901-86D06CF6-A2FC-4CB6-B780-85D76FF4CF74Q37964703-0150A00D-7F31-4BF9-8FDA-A25AC2CD9EF5Q38284468-75BBC585-D215-4496-9F03-563DEE002AD7Q38816614-D643DA0C-33DD-4DF1-B1C0-C62411E9CB9EQ38880522-DCDB9406-9499-4FDA-A3AE-FB8E31DF9361Q38931118-CF68FD81-E90E-4016-B0DB-5C3293CB1B7FQ39215244-20D8032D-77EF-40D1-9E0D-8C5451F7F2F2Q39893350-F3556BBA-1C50-4270-B337-75A0D10BC4F4Q40094752-48AB2312-AC3C-44D5-A1B8-9A61AE1EA87EQ40189236-A0682C03-5A72-4FBE-82E5-4418AAD2951BQ40826259-6AC52487-5138-4F8B-8947-D92FED5C267CQ41991703-E7FE6DEA-7BEC-471D-A01C-2FA72AE49466Q42087125-6502FFBC-524E-406C-AD47-85A1747AE366Q44106107-2A579DED-C7B8-4231-A522-9BC92A57B610Q44705704-296A6EFE-98B8-4FE3-91CF-E6F142F9C0F7Q48117745-E4E42AF3-287A-4FC5-BEFA-019F74F43B0DQ50325686-C2F9E5B2-EF5C-4E68-BAB8-F6232358284CQ57533011-F7930F31-2C58-4F7F-B7AD-C49BDA79E51B
P2860
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
@en
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
@nl
type
label
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
@en
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
@nl
prefLabel
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
@en
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
@nl
P2093
P2860
P1476
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
@en
P2093
Diane Kleinermans
Don Nichols
Katie Greenhalgh
Lynn Purkins
Nolan Wood
P2860
P356
10.1046/J.1365-2125.2003.01994.X
P407
P478
56 Suppl 1
P577
2003-12-01T00:00:00Z